133 related articles for article (PubMed ID: 6446429)
1. Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
Zier KS; Huber C; Albert E; Braunsteiner H
Clin Exp Immunol; 1980 Apr; 40(1):136-46. PubMed ID: 6446429
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.
Sondel PM; O'Brien C; Porter L; Schlossman SF; Chess L
J Immunol; 1976 Dec; 117(6):2197-203. PubMed ID: 1069027
[TBL] [Abstract][Full Text] [Related]
3. Antigens associated with acute leukemia detected in the primed lymphocyte test.
Reinsmoen NL; Kersey JH; Yunis EJ
J Natl Cancer Inst; 1978 Mar; 60(3):537-43. PubMed ID: 146747
[TBL] [Abstract][Full Text] [Related]
4. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
5. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
[TBL] [Abstract][Full Text] [Related]
6. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells.
Lewalle P; Hensel N; Guimaraes A; Couriel D; Jiang Y Z; Mavroudis D; Barrett AJ
Br J Haematol; 1996 Mar; 92(3):587-94. PubMed ID: 8616022
[TBL] [Abstract][Full Text] [Related]
7. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
8. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
9. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
[TBL] [Abstract][Full Text] [Related]
10. The genetics of cell-mediated lympholysis.
Long MA; Handwerger BS; Amos DB; Yunis EJ
J Immunol; 1976 Dec; 117(6):2092-9. PubMed ID: 62806
[TBL] [Abstract][Full Text] [Related]
11. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
12. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
13. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
[TBL] [Abstract][Full Text] [Related]
14. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
15. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions.
Datta AR; Barrett AJ; Jiang YZ; Guimarães A; Mavroudis DA; van Rhee F; Gordon AA; Madrigal A
Bone Marrow Transplant; 1994 Oct; 14(4):517-24. PubMed ID: 7858526
[TBL] [Abstract][Full Text] [Related]
16. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
17. Genetics of cell-mediated lympholysis in man.
Geha RS; Malakian A; Geha O; Yunis E
J Immunol; 1977 Apr; 118(4):1286-91. PubMed ID: 66285
[TBL] [Abstract][Full Text] [Related]
18. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
[TBL] [Abstract][Full Text] [Related]
19. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
Pfeffer PF; Sødal G; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
[TBL] [Abstract][Full Text] [Related]
20. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
